Literature DB >> 7751158

HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies.

P A Morel1, H J Chang, J W Wilson, C Conte, D Falkner, D J Tweardy, T A Medsger.   

Abstract

SSc with ACAs is characterized by limited cutaneous involvement and, in most patients, a mild protracted course. We have studied 104 SSc patients, 47 with ACAs and 57 who were negative for both ACAs and anti-topo I antibodies, for HLA-DR and -DQ associations using DNA typing techniques. Normal controls consisted of 181 healthy individuals. A significant association was observed in the ACA-positive patients with DQB1-0501 (p = 0.001, RR 2.6). There was also a significant decrease in the frequency of DQB1-0201 (p = 0.01, RR 0.33). In addition, the ACA-positive SSc patients were significantly different ethnically from both the other SSc patients and the normal controls (p = 0.004). When patients were stratified according to their ethnic origin and the analysis of HLA associations was repeated, the HLA associations persisted. These results strongly suggest that the development of SSc with ACAs is associated with particular DQB1 alleles, and also that ethnic origin plays a role in disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751158     DOI: 10.1016/0198-8859(94)00078-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

Review 1.  Genetics and proteomics in scleroderma.

Authors:  Carol A Feghali-Bostwick
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

2.  Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.

Authors:  David R Karp; Nishanth Marthandan; Steven G E Marsh; Chul Ahn; Frank C Arnett; David S Deluca; Alexander D Diehl; Raymond Dunivin; Karen Eilbeck; Michael Feolo; Paula A Guidry; Wolfgang Helmberg; Suzanna Lewis; Maureen D Mayes; Chris Mungall; Darren A Natale; Bjoern Peters; Effie Petersdorf; John D Reveille; Barry Smith; Glenys Thomson; Matthew J Waller; Richard H Scheuermann
Journal:  Hum Mol Genet       Date:  2009-11-18       Impact factor: 6.150

3.  HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).

Authors:  M Kuwana; Y Okano; J Kaburaki; H Inoko
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

4.  Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung disease.

Authors:  Matthew Moll; Romy B Christmann; Yuqing Zhang; Michael L Whitfield; Yu Mei Wang; Lisa Rice; Eric Stratton; Robert Lafyatis; Harrison W Farber
Journal:  J Scleroderma Relat Disord       Date:  2018-03-22

Review 5.  Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

Review 6.  Genetic epidemiology: systemic sclerosis.

Authors:  Ariane L Herrick; Jane Worthington
Journal:  Arthritis Res       Date:  2002-01-16

7.  HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients.

Authors:  Tatiana S Rodriguez-Reyna; Pamela Mercado-Velázquez; Neng Yu; Sharon Alosco; Marina Ohashi; Tatiana Lebedeva; Alfredo Cruz-Lagunas; Carlos Núñez-Álvarez; Javier Cabiedes-Contreras; Gilberto Vargas-Alarcón; Julio Granados; Joaquin Zúñiga; Edmond Yunis
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.